Page last updated: 2024-08-18

tetraethylenepentamine and Benign Neoplasms

tetraethylenepentamine has been researched along with Benign Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ando, H; Asai, T; Dewa, T; Okamoto, A; Oku, N; Shimizu, K; Yokota, M	1

Other Studies

1 other study(ies) available for tetraethylenepentamine and Benign Neoplasms

Article	Year
Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapy. The journal of gene medicine, 2013, Volume: 15, Issue:1 Topics: Angiogenesis Inhibitors; Blotting, Western; Cells, Cultured; Ethylenediamines; Gene Expression Regulation; Gene Knockdown Techniques; Gene Transfer Techniques; Human Umbilical Vein Endothelial Cells; Humans; Integrin alpha5; Liposomes; MAP Kinase Kinase 4; MicroRNAs; Microscopy, Confocal; Neoplasms; Neovascularization, Pathologic; Receptors, Lysosphingolipid; RNA Interference; Sphingosine-1-Phosphate Receptors	2013

Article

Year

Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapy.

The journal of gene medicine, 2013, Volume: 15, Issue:1

Topics: Angiogenesis Inhibitors; Blotting, Western; Cells, Cultured; Ethylenediamines; Gene Expression Regulation; Gene Knockdown Techniques; Gene Transfer Techniques; Human Umbilical Vein Endothelial Cells; Humans; Integrin alpha5; Liposomes; MAP Kinase Kinase 4; MicroRNAs; Microscopy, Confocal; Neoplasms; Neovascularization, Pathologic; Receptors, Lysosphingolipid; RNA Interference; Sphingosine-1-Phosphate Receptors

2013